UNCY stock news · Unicycive Therapeutics, Inc.
Get alerts for UNCY
Follow Unicycive Therapeutics, Inc. (UNCY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for UNCYFree on the App Store and Google Play, or on the web.
Unicycive Therapeutics shared its third quarter results and said the FDA accepted its drug application.
Good for UNCYThe FDA accepted Unicycive’s OLC application, set a March 25, 2027 decision date, and the company reported $59 million in cash and investments. This favors UNCY, though approval remains uncertain.